Loading field map
Health Services Research (HSR) is the scientific investigation of how health care is organized, financed, delivered, and experienced, and of what happens to patients and populations as a result. It asks questions that begin with "how," "what," "why," and "what if" about the systems that produce medical care: How do people get access to care? What determines the quality and safety of that care? Why do costs vary so widely for similar treatments? What happens to health outcomes when insurance, payment models, or delivery structures change? The field's defining feature is its focus on the system rather than on the individual clinician-patient encounter. Where clinical medicine asks what treatment works for a given disease, HSR asks what conditions make that treatment available, affordable, timely, and effective for the people who need it.
The stakes are substantial. Health care systems consume a large share of national economies, and their performance varies dramatically across countries, regions, and social groups. HSR provides the evidence base for policy decisions about insurance coverage, hospital regulation, physician payment, drug pricing, and public health programs. It also supplies the methods and findings that health system managers, clinicians, and patient advocates use to improve care. The field is inherently interdisciplinary, drawing on economics, sociology, epidemiology, statistics, political science, and management science, and it operates at the intersection of research and policy.
HSR is organized around a set of enduring questions rather than a single theory. The most fundamental is the relationship between health care and health. Health care is not the only determinant of health—genetics, behavior, social conditions, and environment all matter—but HSR investigates how much of the variation in health outcomes can be attributed to the organization and delivery of medical services. This question immediately raises a second: for whom does care work? Disparities in access, treatment, and outcomes across income, race, geography, and other social categories are a persistent focus. A third central question concerns value: how can the system achieve better outcomes at lower cost, or at least avoid waste? A fourth concerns safety and quality: how often do patients receive the right care, and what happens when they do not?
Several concepts recur throughout the field. Access refers to the timely use of personal health services to achieve the best possible health outcomes. It is usually understood as having multiple dimensions: availability of services, affordability, geographic proximity, and acceptability to patients. Quality is commonly defined through six aims articulated in the early 2000s: care should be safe, effective, patient-centered, timely, efficient, and equitable. Cost is studied both in absolute terms and as a value proposition—what outcomes are purchased for a given expenditure. Utilization describes how often and in what patterns people use services. Outcomes include mortality, morbidity, functional status, patient experience, and financial protection. The field also studies organization, meaning the structures through which care is delivered—hospitals, clinics, integrated delivery systems, accountable care organizations—and financing, meaning the mechanisms through which care is paid for, including insurance, government programs, and out-of-pocket payments.
The roots of HSR lie in the early twentieth century, when physicians and public health officials began systematically documenting variations in surgical practice and hospital care. The most influential early work was the hospital standardization movement led by Ernest Codman, a surgeon who argued that hospitals should track the outcomes of their treatments and make those results public. Codman's "end result" idea—that every patient's outcome should be followed long enough to determine whether treatment was effective—was a direct precursor to modern outcomes research, though it was not called HSR at the time.
The field took its modern shape in the mid-twentieth century, driven by the expansion of health insurance and government involvement in health care. In the United States, the passage of Medicare and Medicaid in 1965 created a pressing need for information about how these programs were working. The 1960s and 1970s saw the establishment of dedicated research units, the development of health economics as a distinct discipline, and the first large-scale studies of medical practice variation. John Wennberg's work in the 1970s on geographic variations in care was particularly influential: he showed that the rate of common surgical procedures varied dramatically across neighboring communities, with no corresponding differences in health outcomes. This finding challenged the assumption that medical practice was driven purely by scientific evidence and opened the door to decades of research on practice patterns, physician decision-making, and the role of supply and demand in health care.
The 1980s and 1990s brought two major developments. First, the rise of managed care in the United States created a natural experiment in health system organization, and HSR researchers studied its effects on costs, quality, and patient satisfaction. Second, the patient safety movement emerged following the publication of the Harvard Medical Practice Study, which estimated that a substantial number of hospitalized patients experienced preventable injuries. This work led to a broader focus on safety as a measurable dimension of quality and to the development of methods for detecting and reducing medical errors.
Internationally, HSR developed in parallel but with different emphases. In the United Kingdom, the National Health Service created a strong tradition of health services research tied to health technology assessment and the evaluation of national policy. In Canada, the field grew alongside publicly funded insurance and focused heavily on access and equity. In continental Europe, health economics and health systems research developed within social insurance traditions, with strong links to epidemiology and public health. In low- and middle-income countries, HSR has increasingly focused on health system strengthening, universal health coverage, and the implementation of interventions in resource-constrained settings. The field is genuinely global, though its methods and priorities reflect the health systems in which it is practiced.
HSR is not a single discipline with one method. It is better understood as a set of overlapping research traditions, each with its own questions, assumptions, and tools. These traditions coexist and often combine within individual studies.
The health economics tradition applies economic theory and econometric methods to health care. Its central assumption is that health care is a good—albeit an unusual one—and that its production, distribution, and consumption can be analyzed using the tools of supply and demand, incentives, and market structure. Health economists study how insurance affects utilization, how physicians respond to payment incentives, how hospitals compete, and how to measure the value of medical interventions. A distinctive contribution is the concept of moral hazard: the idea that insurance reduces the price of care at the point of use, leading people to consume more care than they would if they paid the full cost. Another is the principal-agent problem: the patient (principal) delegates decisions to the physician (agent), whose incentives may not align perfectly with the patient's interests.
The health economics tradition is characterized by a strong preference for quantitative methods, particularly econometric analysis of observational data and, increasingly, randomized controlled trials. It has produced influential frameworks for evaluating health technologies, including cost-effectiveness analysis, which compares the costs and health benefits of alternative interventions. Its limits include the difficulty of capturing non-economic values, the challenge of measuring health outcomes, and the assumption that individuals make rational choices—an assumption that behavioral economics has increasingly questioned.
A second tradition treats HSR as the epidemiology of health care. This approach uses the methods of epidemiology—study design, measurement of exposure and outcome, and analysis of risk factors—to study the distribution and determinants of health care events. Researchers in this tradition study the incidence of hospital-acquired infections, the prevalence of underuse or overuse of specific procedures, the rates of adverse drug events, and the patterns of disease and treatment in populations. The key difference from clinical epidemiology is the focus on the health care system as the exposure: the question is not whether a drug works but whether it is used correctly, safely, and equitably in practice.
This tradition has been particularly influential in quality measurement and patient safety. It developed the methods for chart review, administrative data analysis, and surveillance that underpin modern quality reporting. It also contributed the concept of appropriateness—whether a procedure is indicated for a given patient—and the methods for measuring it, such as the RAND/UCLA appropriateness method, which combines literature review with expert panel judgment.
A third tradition draws on sociology, organizational theory, and political science. It treats health care organizations as complex social systems and asks how their structures, cultures, and environments shape behavior. Researchers in this tradition study how hospitals implement new technologies, how professional hierarchies affect communication and error, how organizational culture influences safety, and how policy changes are translated into practice. The methods are often qualitative—interviews, ethnography, case studies—though mixed methods are common.
This tradition has been central to understanding the gap between evidence and practice. It explains why interventions that work in controlled trials often fail in real-world settings: the social and organizational context matters. It also contributed the concept of implementation science, which studies the strategies used to integrate evidence-based interventions into routine care. Implementation science has grown rapidly since the early 2000s and now constitutes a distinct subfield, but its intellectual roots lie in the sociological tradition of HSR.
A fourth tradition compares health systems across countries or regions. It asks how different ways of organizing, financing, and delivering care produce different outcomes. Comparative researchers study questions such as: Why do some countries achieve universal coverage at lower cost? How do different payment systems affect physician behavior? What explains cross-national differences in life expectancy, infant mortality, or patient satisfaction?
This tradition is methodologically diverse, combining quantitative analysis of cross-national data with qualitative case studies. Its main challenge is the difficulty of causal inference: countries differ in many ways, and isolating the effect of a single policy or institutional feature is hard. Nevertheless, comparative research has been influential in policy debates, particularly in showing that high-performing systems share certain features—such as strong primary care, universal coverage, and limited administrative complexity—even though they achieve these features through different mechanisms.
A fifth tradition, closely related to but distinct from the others, is health technology assessment (HTA). HTA is the systematic evaluation of the properties, effects, and impacts of health technologies—drugs, devices, procedures, and organizational interventions. It emerged in the 1970s and 1980s as governments and insurers needed evidence to decide which technologies to cover and reimburse. HTA typically combines clinical effectiveness reviews, economic evaluation, and sometimes ethical and social analysis. It is more explicitly decision-oriented than other HSR traditions: its purpose is to inform coverage decisions, clinical guidelines, and pricing negotiations.
HTA has become institutionalized in many countries through agencies such as the National Institute for Health and Care Excellence (NICE) in England and the Institute for Quality and Efficiency in Health Care (IQWiG) in Germany. Its methods—particularly cost-effectiveness analysis and the use of quality-adjusted life years (QALYs)—have been influential across the field, though they remain controversial. Critics argue that QALYs can undervalue the lives of people with disabilities and that cost-effectiveness thresholds are arbitrary. Proponents respond that explicit rationing is preferable to implicit rationing and that HTA makes trade-offs transparent.
These traditions are not mutually exclusive, and most HSR studies draw on more than one. A study of hospital readmissions might use epidemiological methods to measure the rate, economic analysis to estimate the cost, and organizational theory to explain why some hospitals have higher rates than others. The traditions differ in their assumptions and preferred methods, but they share a common object of study and a common commitment to empirical evidence.
The most productive relationships are often between traditions that seem furthest apart. Health economics and organizational sociology, for example, have historically had little dialogue, but the rise of behavioral economics and implementation science has created bridges. Similarly, comparative health systems research and health technology assessment have converged in the study of health system performance: HTA provides evidence on what works, and comparative research provides evidence on how to deliver it at scale.
There are also genuine tensions. Health economists tend to emphasize incentives and individual choice, while sociologists emphasize structure and culture. These are not merely different perspectives; they lead to different predictions about how systems will respond to change. A payment reform that economists predict will improve efficiency may fail in practice because it does not account for professional norms or organizational routines. The field's strength lies in maintaining these tensions rather than resolving them prematurely.
HSR uses the full range of social science and epidemiological methods. Quantitative methods include analysis of administrative data (insurance claims, hospital discharge records, vital statistics), surveys of patients and providers, randomized controlled trials, quasi-experimental designs (difference-in-differences, regression discontinuity, instrumental variables), and simulation modeling. Qualitative methods include interviews, focus groups, ethnography, and document analysis. Mixed-methods designs, which combine quantitative and qualitative approaches, are increasingly common and are often necessary to answer both "what happened" and "why it happened."
A distinctive feature of HSR is its reliance on natural experiments. Because it is often impossible or unethical to randomize health system features, researchers exploit natural variation: a policy change in one state but not another, a sudden change in insurance coverage, a discontinuity in eligibility rules. The credibility revolution in empirical economics, which emphasized careful identification of causal effects, has had a major influence on HSR methods. Researchers now pay close attention to whether their designs can support causal claims, and the field has become more rigorous about distinguishing correlation from causation.
Data infrastructure is central to the field. Many countries have established linked databases that combine administrative, clinical, and sometimes social data. The Nordic countries, with their comprehensive registries, are particularly strong in this regard. The United States has a fragmented system of data sources, including Medicare claims, private insurance databases, and electronic health records, which creates both opportunities and challenges. The growing availability of electronic health record data has opened new possibilities for research but also raised new questions about privacy, data quality, and generalizability.
HSR today is a mature, institutionalized field with dedicated departments, journals, funding programs, and professional societies. It is also a field in flux, responding to several developments in the broader health care environment.
The first is the shift toward value-based care. Many health systems are moving away from paying for volume (fee-for-service) and toward paying for value, through mechanisms such as bundled payments, accountable care organizations, and pay-for-performance. HSR is central to evaluating whether these reforms achieve their goals and to understanding their unintended consequences. The evidence so far is mixed: some reforms have produced modest improvements, while others have had little effect or have led to gaming of the system.
The second is the rise of digital health and artificial intelligence. Telemedicine, wearable devices, and machine learning algorithms are transforming the delivery of care. HSR is beginning to study these technologies, asking whether they improve access, quality, and equity, and how they should be regulated and reimbursed. The field faces a particular challenge here: the pace of technological change outstrips the pace of traditional research, and new methods are needed to evaluate rapidly evolving interventions.
The third is the growing attention to health equity. The COVID-19 pandemic exposed and exacerbated disparities in health and health care across racial, ethnic, and socioeconomic groups. HSR has responded with increased attention to structural racism, social determinants of health, and the mechanisms through which systems produce inequities. This work is methodologically challenging because it requires linking health care data with social data and because disparities are produced by complex interactions of individual, organizational, and societal factors.
The fourth is the globalization of the field. HSR is no longer dominated by North America and Western Europe. Researchers in low- and middle-income countries are producing important work on health system strengthening, universal health coverage, and the implementation of interventions in resource-constrained settings. This work has enriched the field by challenging assumptions that were developed in wealthy countries and by developing methods that are appropriate for different contexts.
The field's enduring contribution is its insistence that health care systems are not natural phenomena but human creations—and that they can be studied, understood, and improved. HSR does not provide simple answers, but it provides the evidence and the analytical tools that make informed decisions possible. Its central message is that the organization of care matters: it shapes who gets care, what care they receive, how much it costs, and whether it helps.